Document Detail


Implications of altering the rate of carbohydrate absorption from the gastrointestinal tract.
MedLine Citation:
PMID:  8549016     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The rate of absorption of carbohydrate from the small intestine plays a major role in determining the metabolic effects of dietary carbohydrate. Factors which reduce the rate of absorption include the nature of the starch and sugars, and the presence of vegetable proteins, fats, viscous fibre, and antinutrients, including lectins and phytates. The rate of absorption can also be manipulated by the use of specific enzyme inhibitors and by increasing the number and frequency of meals while holding caloric intake constant. All these factors contribute to the creation of what may be termed slow release or "lente carbohydrate". The slowing of small intestinal absorption, as exemplified by increased meal frequency ("nibbling"), results in reduced postprandial insulin secretion and lower low-density lipoprotein (LDL) cholesterol and apolipoprotein B concentrations. A further effect of some manipulations which reduce the rate of absorption is increased delivery of carbohydrate to the colon and its absorption after bacterial fermentation to short-chain fatty acids (SCFA). These SCFA may have beneficial effects on colonic health(butyrate) or further inhibit cholesterol synthesis in the liver (propionate). Thus the absorption of "lente carbohydrate" takes place along the full length of the gastrointestinal tract with a wide variety of physiological consequences.
Authors:
D J Jenkins; R G Josse; A L Jenkins; T M Wolever; V Vuksan
Related Documents :
2906586 - Induction of monooxygenase activity in the intestine of spot (leiostomus xanthurus), a ...
8257146 - Effects of magnesium-aluminum hydroxide antacid on absorption of rufloxacin.
8169536 - Reevaluation and application of the dual-isotope plasma ratio method for the measuremen...
2516126 - Sugar-dependent selective induction of mouse jejunal disaccharidase activities.
2400346 - Topical timolol decreases plasma high-density lipoprotein cholesterol level.
8546436 - Vitamin intakes (a, e, c, carotenes) in a french institution: assessment by the duplica...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Clinical and investigative medicine. Médecine clinique et experimentale     Volume:  18     ISSN:  0147-958X     ISO Abbreviation:  Clin Invest Med     Publication Date:  1995 Aug 
Date Detail:
Created Date:  1996-02-22     Completed Date:  1996-02-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7804071     Medline TA:  Clin Invest Med     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  296-302     Citation Subset:  IM    
Affiliation:
Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Faculty of Medicine, University of Toronto, Ontario.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Carbohydrates / pharmacokinetics*
Cookery
Digestive System / metabolism*
Feeding Behavior
Food
Humans
Intestinal Absorption / physiology
Particle Size
Starch / pharmacokinetics
Chemical
Reg. No./Substance:
0/Carbohydrates; 9005-25-8/Starch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Traditional pharmacological management of non-insulin-dependent diabetes.
Next Document:  The mechanism of alpha-glucosidase inhibition in the management of diabetes.